Antibody-based immunotherapy (monoclonal antibodies) is priced per cycle — not as one fixed figure. This practical guide explains what moves the monoclonal antibody cost, how insurance and schemes help, and how to get a clear, written estimate at CION.
If you have been told immunotherapy is part of your lymphoma plan, the first thing to know is that there is no single price. Antibody-based immunotherapy — the use of a laboratory-made monoclonal antibody that locks onto a specific marker on lymphoma cells — is billed per cycle. The total depends on your dose, your subtype, how many cycles are planned, and whether the antibody is used alone or added to chemotherapy. That is why an accurate monoclonal antibody cost only comes after your reports are reviewed.
This page is written to help you understand exactly what moves the antibody therapy price for lymphoma, so you can plan finances with clear eyes rather than a scary headline number. For the full treatment-cost picture, see our lymphoma treatment cost in Hyderabad page; for the therapy itself, see Lymphoma Treatment in Hyderabad and the main lymphoma hub.
Immunotherapy is delivered directly at CION as day-care infusions by our medical oncology and haematology team — you are not referred elsewhere for it. When you are ready, get a free cost estimation built around your actual diagnosis.
Many B-cell lymphomas carry a surface marker called CD20, and this is what makes antibody immunotherapy possible — the antibody is designed to lock onto that exact marker. Because the target is confirmed on your biopsy tissue, immunotherapy is a form of targeted treatment rather than a blanket one. Whether an antibody will help you at all depends on the markers found on your lymphoma cells. (Source: NCCN and ESMO lymphoma guidelines, which base antibody therapy decisions on confirmed cell-surface markers.)
Six factors decide the antibody therapy price for lymphoma. Understanding them helps you read any estimate — and see why two patients can pay very different amounts.
| Cost factor | Why it matters |
|---|---|
| Dose (weight / body surface area) | The antibody is dosed by your weight or surface area, so a larger person needs more drug per cycle — the single biggest driver of drug cost. |
| Number of cycles | Set by your subtype, stage and how the disease responds. More cycles means a higher total, even at the same per-cycle price. |
| Alone or with chemotherapy | Antibody immunotherapy is often combined with alkylating or other chemotherapy, which adds drug and day-care costs. |
| Antibody class & biosimilar option | The specific drug class, and whether a quality-assured biosimilar is clinically suitable, can substantially change the figure. |
| Day-care & pre-medication | Each infusion carries day-care, pre-medication and observation charges on top of the drug itself. |
| Monitoring tests | Blood counts and response scans (such as a PET-CT) are part of the overall cost of a course. |
This table explains cost drivers, not prices. Actual figures vary by individual and are only accurate after your reports are reviewed. We describe therapies by drug class and mechanism; specific regimen names and schedules are covered on the treatment page.
Costs differ widely by treatment type. Which one is right for you depends entirely on your diagnosis — never on price. This is a rough ordering to help you plan.
A monoclonal antibody targeting a surface marker (such as CD20 or CD30), given as day-care infusions directly at CION, often with chemotherapy. Priced per cycle; usually less costly per course than cell-based therapies.
Cytotoxic drugs, frequently given alongside antibody immunotherapy. See what affects lymphoma chemotherapy cost for the full breakdown of its own cost drivers.
An intensive, cell-based treatment that CION coordinates through accredited partner facilities. Typically far more expensive — see CAR T-cell therapy cost in India.
Also coordinated through accredited partner facilities, not delivered in-house. Generally among the highest-cost options — see stem cell transplant cost for lymphoma.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No headline number — a written, itemised breakdown of the antibody drug cost, cycles and day-care charges, with insurance and scheme cover checked for you.
A monoclonal antibody is a protein made in the laboratory to recognise one specific marker on the surface of lymphoma cells. Many B-cell lymphomas display the CD20 marker; some other subtypes carry CD30. When the antibody attaches to that marker, it flags the cell for the immune system to destroy or blocks a signal the cell relies on. Because it acts on a target rather than on all rapidly dividing cells, it is called targeted immunotherapy.
This is directly relevant to cost. The marker on your biopsy decides whether an antibody can help at all, and which class is appropriate — and different classes are priced differently. Confirming the target through pathology is therefore not an optional extra; it is what makes the treatment (and its cost) meaningful. Antibody immunotherapy, chemotherapy, targeted therapy and radiation (IMRT) are all delivered directly by CION; more intensive cell-based options are coordinated with accredited partners.
An estimate is only useful if it is honest and itemised. When you request one, we set out each part so there are no surprises later:
To prepare this accurately we need your biopsy and pathology report, recent scans, and your treatment history. Send your details and we will build it for you at no cost.
The antibody therapy price for lymphoma is often lower than families first fear, because several routes exist to reduce what you actually pay:
Antibody immunotherapy given as part of an approved lymphoma plan is generally covered under hospitalisation or day-care benefits, subject to your policy terms and sum insured. CION runs a cashless desk with empanelled insurers and handles pre-authorisation. Our guide to insurance and cashless cover for lymphoma explains what to expect.
Depending on your state and eligibility, a government scheme may cover a substantial part of treatment. See whether Aarogyasri covers lymphoma treatment in Telangana, or, in Andhra Pradesh, NTR Vaidya Seva. Our team checks your eligibility as part of the estimate.
Where a suitable biosimilar of the required antibody class is approved, it can meaningfully lower cost without compromising the treatment intent. This is a clinical decision made by your medical oncologist based on your subtype and confirmed marker — not on price alone — and it is always reflected transparently in your written estimate.
Outcomes in lymphoma are among the most encouraging in oncology — and antibody immunotherapy has been part of that progress. Published series report roughly 80–90% long-term survival for many people with Hodgkin lymphoma, and around 60–70% for diffuse large B-cell lymphoma (a common non-Hodgkin subtype). These are population figures that vary considerably by individual, subtype, stage and response, so your own outlook can only be judged by your treating team. (Source: figures consistent with NCCN and ESMO lymphoma guidelines and published survival series.)
Because immunotherapy is priced per cycle and the plan hinges on your confirmed markers, a second opinion is genuinely worth it before you start — both clinically and financially. It is especially valuable when:
CION offers a free written second opinion and a plan built around healing, not billing, with transparent costs up front. Learn what makes a good lymphoma treatment centre, read more about getting a second opinion for lymphoma, or connect with our best lymphoma doctors in Hyderabad at the best lymphoma hospital in Hyderabad. Request your free estimate or call 18002028726.
Get a free written second opinion and an itemised cost estimate from CION's lymphoma team — with insurance and scheme cover checked before anything begins.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.There is no single price — antibody-based immunotherapy for lymphoma is billed per cycle, and the total depends on the drug class used, your body weight and surface area (which set the dose), how many cycles are planned, and whether it is given alone or added to chemotherapy. As a broad guide, a single antibody infusion cycle commonly runs into the tens of thousands to a few lakh rupees, and a full course is usually several cycles. Because the true figure is so individual, the honest answer only comes after your reports are reviewed. The clearest next step is a written, itemised estimate — request a free cost estimation and see our lymphoma treatment cost in Hyderabad page for the wider picture.
A monoclonal antibody is a laboratory-made protein designed to lock onto a specific marker on the surface of lymphoma cells — for example the CD20 marker found on many B-cell lymphomas, or CD30 on some other subtypes. Once attached, it flags those cells for the immune system to destroy or blocks a signal the cell needs. Because it targets a marker rather than dividing cells generally, it is a form of targeted immunotherapy. The relevant marker is confirmed on your biopsy tissue before treatment. We describe therapies by drug class and mechanism here; for the specific regimen names and schedules, see Lymphoma Treatment in Hyderabad.
Several factors move the antibody therapy price for lymphoma. The dose is calculated from your weight or body surface area, so a larger person needs more drug per cycle. The number of cycles depends on your subtype, stage and how the disease responds. Whether the antibody is used alone or combined with alkylating or other chemotherapy changes both drug and day-care costs. Pre-medication, day-care infusion charges, and monitoring blood tests add to each cycle. Finally, the specific antibody class and whether a quality-assured biosimilar option is suitable can substantially change the figure. This is exactly why we give an itemised, per-cycle estimate rather than a single headline number — get a cost estimation.
In most cases, yes — antibody-based immunotherapy given as part of an approved lymphoma treatment plan is generally covered under hospitalisation or day-care benefits of health insurance policies, subject to your sum insured and terms. CION runs a cashless desk with empanelled insurers and helps with pre-authorisation. Government schemes may also apply: see whether Aarogyasri covers lymphoma treatment in Telangana or NTR Vaidya Seva in Andhra Pradesh. Our team also explains insurance and cashless cover for lymphoma in detail so you know what is reimbursed before you start.
Biosimilars are follow-on versions of an original biologic antibody, approved after they are shown to be highly similar in structure, efficacy and safety. Where a suitable, quality-assured biosimilar of the required antibody class exists, it can meaningfully lower the antibody therapy price for lymphoma without compromising the treatment intent. The decision is a clinical one made by your medical oncologist based on your subtype, the target marker on your biopsy, and regulatory approval — not on price alone. If a biosimilar option is appropriate for you, it will be discussed openly and reflected transparently in your written estimate.
Antibody immunotherapy targets a specific marker on lymphoma cells and is delivered directly at CION as day-care infusions; chemotherapy uses cytotoxic drugs and is often given alongside it. CAR T-cell therapy and stem cell transplant are more intensive, cell-based treatments that CION coordinates through accredited partner facilities — and they typically cost considerably more. As a rough ordering, antibody immunotherapy and chemotherapy are usually less expensive per course than CAR T-cell therapy or a stem cell transplant for lymphoma. Which is right for you depends entirely on your diagnosis, not on cost.
Yes — CION provides a free, written, itemised cost estimation. It sets out the antibody drug cost per cycle, the number of planned cycles, day-care infusion and pre-medication charges, monitoring blood tests, and any concurrent chemotherapy, so there are no surprises. We also flag where insurance or a government scheme is likely to apply. To prepare it accurately we need your biopsy and pathology report, recent scans (such as a PET-CT), and your treatment history. You are welcome to use this alongside a free second opinion. Request your estimate here.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.